Research

Joint KDIGO-ISN Paper Highlights Need for Access to Affordable Diagnostic Tools

[vc_row][vc_column][vc_column_text]The paper, “Availability and Affordability of Kidney Health Laboratory Tests around the Globe,” has been published in the American Journal of Nephrology. The manuscript, produced by the KDIGO Controversies Conference leaders in collaboration with ISN, surveyed a representative subset of ISN-Global Kidney Health Atlas (ISN-GKHA) respondents from April to June 2020 to ascertain the availability and...

An Incredible Year for ISN Research Initiatives

[vc_row][vc_column][vc_column_text]The ISN had an exciting start to research projects in 2020 with the Research Collaborative Meeting and 1ST International Consensus Meeting on Defining Kidney Failure in Clinical Trials that took place from January 31 - February 1 in Vancouver, Canada. The ISN convened this international, multi-stakeholder meeting to develop consensus on definitions of kidney failure...

ISN Is Pleased to Announce Four New Named Fellows

[vc_row][vc_column][vc_column_text]The ISN Executive Committee and Council have approved four “ISN-Named Fellows.” These ISN members – early-career nephrologists – have contributed significantly to various outputs of ISN’s research activities. Find out more about these ISN-Named Fellows here.[/vc_column_text][/vc_column][/vc_row][vc_row css=".vc_custom_1608307298423{margin-top: 5px !important;margin-bottom: 5px !important;border-bottom-width: 1px !important;padding-top: 5px !important;padding-bottom: 5px !important;border-bottom-color: #c1c1c1 !important;border-bottom-style: dotted !important;}"][vc_column][vc_column_text]ISN GKHA Fellow – Isabelle Ethier Dr....

ISN-KDIGO Survey on Global Availability and Affordability of Kidney Health Laboratory Tests Featured in AJN

[vc_row][vc_column][vc_column_text]The American Journal of Nephrology (AJN) has published the ISN-KDIGO manuscript, “Availability and Affordability of Kidney Health Laboratory Tests Around the Globe.” Read the full, open-access article here. Laboratory testing of kidney health measures is essential to diagnose and monitor kidney diseases. The availability and affordability of kidney health laboratory tests across countries remain largely undefined. The...

Global Trials Focus

[vc_row][vc_column][vc_column_text]Every month the ISN-ACT Team lists interesting new randomized controlled trials (RCTs) from around the world. Highlight: Corticosteroids and cyclophosphamide may be superior to tacrolimus and rituximab in the treatment of primary membranous nephropathy at the cost of increased adverse events See the latest trials here. A summary of the highlighted trial is now available in French,...

2019 ISN GKHA Survey Results on Disparities in Kidney Care Featured in Publications

[vc_row][vc_column][vc_column_text]The ISN Global Kidney Health Atlas (GKHA) aims to improve understandings of inter-and intra-national variability worldwide in terms of the capacity to deliver care for patients with kidney diseases. The 2019 GKHA survey used the WHO universal health coverage (UHC) domains, which summarize and compare the availability, accessibility, and affordability of high-quality care for patients...

Global Trials Focus

[vc_row][vc_column][vc_column_text]Every month the ISN-ACT Team lists interesting new randomized controlled trials (RCTs) from around the world. Highlight: SGLT-2 inhibition strikes again Dapagliflozin in Patients with Chronic Kidney Disease See the latest trials here. A summary of the highlighted trial is now available in French, Mandarin, and Spanish. Support equal access to nephrology research: Become an ISN Member![/vc_column_text][/vc_column][/vc_row]

Explore Ongoing Research and Share Your Data on the ISN Observatory of CKDu

[vc_row][vc_column][vc_column_text]The ISN i3C (International Consortium CKDu Collaborators) group developed the ISN Observatory of CKDu as part of its Collaboration Plan with the World Health Organization (WHO) to facilitate information exchange and raise awareness of the urgent issue of Chronic Kidney Disease of unknown etiology. Collating ongoing studies and efforts on CKDu provides a valuable overview...

GLOBAL TRIALS FOCUS

[vc_row][vc_column][vc_column_text]Every month the ISN-ACT Team lists interesting new randomized controlled trials (RCTs) from around the world. Highlight: LOL-HD study: Laughter therapy may reduce depressive symptoms in hemodialysis patients See the latest trials here. A summary of the highlighted trial is now available in French, Spanish, and Mandarin. Support equal access to nephrology research: Become an ISN Member![/vc_column_text][/vc_column][/vc_row]

Save The Date- Webinar: SGLT2i in Diabetic and Non-Diabetic Kidney Diseases

[vc_row][vc_column][vc_column_text]The webinar, Gathering Wisdom: SGLT2i in Diabetic and Non-Diabetic Kidney Diseases, will be held on November 9, 2020, at 3 p.m. CET.  This symposium will focus on the current state of therapeutic options for CKD and DKD, with specific attention to accumulating evidence of recent SGLT2i trials.  The webinar is supported by an unrestricted educational grant by AstraZeneca.  Registration details will follow shortly. [/vc_column_text][/vc_column][/vc_row]